Wednesday, June 10, 2026

pharma Β· Acute Myeloid Leukemia Β· Narcolepsy Β· JAZZ

Jazz Pharmaceuticals Ireland

Jazz Pharmaceuticals Ireland clinical programs β€” 208 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Waterloo Exchange, Waterloo Road, Dublin, 4, IE HQ
2003 Founded
3,631 Employees
Public company Type
JAZZ Β· NYSE Ticker
Company details
Status
Public
HQ
Waterloo Exchange, Waterloo Road, Dublin, 4, IE
Founded
2003
Employees
3,631
Programs
208
Drugs
91
Patents
89
Intelligence Β· Clinical Programs

Jazz Pharmaceuticals Ireland projects

208 ClinicalTrials.gov programs sponsored by Jazz Pharmaceuticals Ireland.

Jazz Pharmaceuticals Ireland has 208 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

Page 5 of 5
  1. Cannabidiol

    Jazz Pharmaceuticals Ireland Limited

    Lennox Gastaut Syndrome

    approved small molecule active

    1 trial
  2. Cannabidiol (Epidiolex)

    Jazz Pharmaceuticals Ireland Limited

    Study the Efficacy of Epidiolex for Typical Absence Seizures

    approved small molecule completed

    1 trial
  3. Cannabidiol Oral Solution [Epidiolex]

    Jazz Pharmaceuticals Ireland Limited

    Tuberous Sclerosis Complex Associated Neuropsychiatric Disease

    approved small molecule completed

    1 trial
  4. Epidiolex 100 mg/mL Oral Solution

    Jazz Pharmaceuticals Ireland Limited

    Dravet Syndrome (DS)

    approved small molecule active

    1 trial
  5. GWP42003-P

    Jazz Pharmaceuticals Ireland Limited

    Lennox-Gastaut Syndrome

    approved small molecule terminated

    1 trial
  6. JZP-258

    Jazz Pharmaceuticals Ireland Limited

    Narcolepsy

    approved small molecule completed

    1 trial
  7. JZP258

    Jazz Pharmaceuticals Ireland Limited

    Narcolepsy

    approved small molecule completed

    1 trial
  8. JZP258 (XYWAV)

    Jazz Pharmaceuticals Ireland Limited

    Idiopathic Hypersomnia

    approved small molecule completed

    1 trial
  9. Placebo

    Jazz Pharmaceuticals Ireland Limited

    Chronic Fatigue Syndrome

    approved small molecule terminated

    1 trial
  10. Rapydan

    Jazz Pharmaceuticals Ireland Limited

    Healthy

    approved small molecule terminated

    1 trial
  11. Sativex

    Jazz Pharmaceuticals Ireland Limited

    Multiple Sclerosis

    approved small molecule completed

    2 trials
  12. Sodium Oxybate

    Jazz Pharmaceuticals Ireland Limited

    REM Sleep Behavior Disorder

    approved small molecule completed

    1 trial
  13. Solriamfetol

    Jazz Pharmaceuticals Ireland Limited

    Binge Eating Disorder

    approved small molecule active

    1 trial
  14. Xyrem (X)

    Jazz Pharmaceuticals Ireland Limited

    Obstructive Sleep Apnea Syndrome

    approved small molecule completed

    1 trial
  15. sodium oxybate

    Jazz Pharmaceuticals Ireland Limited

    Sleep

    approved small molecule completed

    1 trial
  16. Ultrasound Elastography

    Jazz Pharmaceuticals Ireland Limited

    Bone Marrow Transplant Complications

    other active

    1 trial

Frequently asked questions

How many clinical projects does Jazz Pharmaceuticals Ireland have?

208 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.